On Sept. 23, 2020, the World Health Organization (WHO) with the United Nations, specialised agencies and partners called…
On Sept. 22, 2020, Sanofi and GSK announcement showcased their unwavering commitment to develop a COVID-19 vaccine that…
On Sept. 22, 2020, Sinovac Biotech announced that it had recently commenced phase III clinical trials for its…
On Sept. 22, 2020, Codagenix announced that the Serum Institute of India has begun manufacturing CDX-005, the company’s…
On Sept. 21, 2020, the first study comparing the immune responses of adults and children with COVID-19 has…
On Sept. 18, 2020, Roche announced the launch of its Elecsys Anti-SARS-CoV-2 S antibody test for markets accepting…
On Sept. 18, 2020, Sanofi and GSK finalised and signed an advanced purchase agreement with the European Commission…
On Sept. 17, 2020, BioNTech announced an agreement with Novartis to acquire their GMP certified manufacturing facility in…
On Sept. 17, 2020, Atossa Therapeutics announced a positive interim safety assessment from the second cohort of healthy…
On Sept. 16, 2020, a study by researchers at La Jolla Institute for Immunology published in the Cell,…
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
On Sept. 15, 2020, Thermo Fisher Scientific announced it was investing more than $140 million to further expand…
On Sept. 15, 2020, Soligenix, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare…
On Sept. 15, 2020,Tonix Pharmaceuticals announced that the first patient was enrolled in the observational COV-LOGIC study (TNX-C001),…
On Sept. 15, 2020, Novavax announced an amendment to its existing agreement with Serum Institute of India which…
On Sept. 15, 2020, BioNTech announced that it will receive a grant of up to 375 million Euro…
On Sept. 14, 2020, scientists at the Max Planck Institute for Infection Biology in Berlin and the Institut…
On Sept. 14, 2020, Valneva announced a vaccine partnership with the UK government for its inactivated COVID-19 vaccine,…
On Sept. 14, 2020, Vaxart announced that the U.S. Food and Drug Administration (FDA) has completed its review…
On Sept. 14, 2020, Dynavax Technologies announced a commercial partnership for the supply of Dynavax’s CpG 1018 adjuvant…
On Sept. 12 2020, Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK…
On Sept. 12, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
On Sept. 11, 2020, MediciNova announced that BioComo, co-developer of MediciNova’s SARS-CoV-2 vaccine for COVID-19, announced that its…
On Sept. 9, 2020, Merck announced that two Phase 3 studies evaluating the safety, tolerability and immunogenicity of…
On Sept. 9, 2020, as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus…
On Sept. 9, 2020, the American Academy of Family Physicians (AAFP) reviewed and agreed with the Advisory Committee…
On Sept. 9, 2020, Valneva announced the signing of a new contract, lasting up to three years, with…
On Sept. 9, 2020, Pfizer and BioNTech announced preliminary preclinical data in mouse and non-human primate models from…
On Sept. 9, 2020, Pfizer and BioNTech announced that they had concluded exploratory talks with the European Commission…
On Sept. 9, 2020, iBio announced that it had selected IBIO-201, its LicKM-ubunit vaccine, as its leading candidate…